Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126514211 | 12651421 | 1 | I | 20160810 | 0 | 20160812 | 20160812 | DIR | 62.44 | YR | M | N | 130.60000 | KG | 20160811 | N | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126514211 | 12651421 | 1 | PS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 0 | 1185 | MG | ||||||||||
| 126514211 | 12651421 | 2 | SS | FLUDARABINE PHOSPHATE. | FLUDARABINE PHOSPHATE | 1 | 0 | 105 | MG | ||||||||||
| 126514211 | 12651421 | 3 | SS | RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | RITUXIMAB | 1 | 0 | 1310 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126514211 | 12651421 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126514211 | 12651421 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126514211 | 12651421 | 1 | 20160728 | 0 | ||
| 126514211 | 12651421 | 2 | 20160728 | 0 | ||
| 126514211 | 12651421 | 3 | 20160726 | 0 |